• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种支持全球宫颈癌筛查和基于风险的管理的快速人乳头瘤病毒分型检测方法:一项横断面研究。

A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study.

作者信息

Inturrisi Federica, de Sanjosé Silvia, Desai Kanan T, Dagnall Casey, Egemen Didem, Befano Brian, Rodriguez Ana Cecilia, Jeronimo Jose A, Zuna Rosemary E, Hoffman Amanda, Farhat Nozzari Sepideh, Walker Joan L, Perkins Rebecca B, Wentzensen Nicolas, Palefsky Joel M, Schiffman Mark

机构信息

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA.

ISGlobal, Barcelona, Spain.

出版信息

Int J Cancer. 2024 Jan 15;154(2):241-250. doi: 10.1002/ijc.34698. Epub 2023 Sep 29.

DOI:10.1002/ijc.34698
PMID:37772799
Abstract

The World Health Organization recommends human papillomavirus (HPV) testing for cervical screening. Extended genotyping can identify the highest-risk HPV-positive women. An inexpensive, rapid, mobile isothermal amplification assay (ScreenFire HPV RS test) was recently redesigned to yield four channels ordered by cancer risk (ie, hierarchical approach): HPV16, HPV18/45, HPV31/33/35/52/58 and HPV39/51/56/59/68. Stored specimens from 2076 women (mean age 30.9) enrolled in a colposcopy clinic, with high HPV prevalence, were tested with ScreenFire. We calculated hierarchical channel positivity and non-hierarchical channel and type positivity, according to histologic diagnosis (256 cancer, 350 cervical intraepithelial neoplasia [CIN]3, 409 CIN2, 1020 < CIN2) and known virologic reference results (Linear Array and TypeSeq). Additionally, we analyzed ScreenFire time-to-positive up to 60 min by channel and histology. Overall clinical sensitivity for CIN3+ was 94.7% (95% confidence interval 92.6-96.4), similar to Linear Array (92.3, 89.7-94.3) and TypeSeq (96.0, 93.9-97.6). Sensitivity was high for all types and channels. The hierarchical approach was well in line with HPV typing and histologic diagnosis, prioritizing higher risk women having HPV16 and precancer. For HPV16, time-to-positive was shorter in women with precancer. ScreenFire showed excellent agreement with research reference typing tests and detection of CIN2+. Risk-based type results could help guide clinical management of HPV-positive women. Time-to-positive combined with genotyping might be useful. ScreenFire is rapid, mobile, relatively inexpensive and designed for implementation of HPV-based screening and management, including in lower-resource settings. Further validation in screening by self-sampling and practical effectiveness merit evaluation.

摘要

世界卫生组织建议采用人乳头瘤病毒(HPV)检测进行宫颈癌筛查。扩展基因分型可识别出HPV阳性且风险最高的女性。最近对一种廉价、快速、可移动的等温扩增检测方法(ScreenFire HPV RS检测)进行了重新设计,以产生按癌症风险排序的四个通道(即分层方法):HPV16、HPV18/45、HPV31/33/35/52/58和HPV39/51/56/59/68。对一家阴道镜诊所中2076名女性(平均年龄30.9岁)的储存样本进行了ScreenFire检测,这些女性的HPV感染率较高。我们根据组织学诊断(256例癌症、350例宫颈上皮内瘤变[CIN]3、409例CIN2、1020例<CIN2)和已知的病毒学参考结果(线性阵列和TypeSeq)计算了分层通道阳性率以及非分层通道和类型阳性率。此外,我们分析了ScreenFire在长达60分钟内按通道和组织学分类的阳性时间。CIN3+的总体临床敏感性为94.7%(95%置信区间92.6 - 96.4),与线性阵列(92.3,89.7 - 94.3)和TypeSeq(96.0,93.9 - 97.6)相似。所有类型和通道的敏感性都很高。分层方法与HPV分型和组织学诊断非常吻合,将感染HPV16和癌前病变的高风险女性列为优先考虑对象。对于HPV16,癌前病变女性的阳性时间更短。ScreenFire与研究参考分型检测以及CIN2+的检测结果高度一致。基于风险的分型结果有助于指导HPV阳性女性的临床管理。阳性时间与基因分型相结合可能会很有用。ScreenFire快速、可移动、相对廉价,专为基于HPV的筛查和管理而设计,包括在资源较少的环境中。通过自我采样进行筛查的进一步验证以及实际效果值得评估。

相似文献

1
A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study.一种支持全球宫颈癌筛查和基于风险的管理的快速人乳头瘤病毒分型检测方法:一项横断面研究。
Int J Cancer. 2024 Jan 15;154(2):241-250. doi: 10.1002/ijc.34698. Epub 2023 Sep 29.
2
Redesign of a rapid, low-cost HPV typing assay to support risk-based cervical screening and management.一种快速、低成本的 HPV 分型检测方法的重新设计,以支持基于风险的宫颈癌筛查和管理。
Int J Cancer. 2022 Oct 1;151(7):1142-1149. doi: 10.1002/ijc.34151. Epub 2022 Jun 24.
3
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.25 岁及以上女性宫颈癌筛查中致癌型人乳头瘤病毒(HPV)检测及 HPV16 或 HPV18 基因分型的性能:ATHENA 研究的一项亚组分析。
Lancet Oncol. 2011 Sep;12(9):880-90. doi: 10.1016/S1470-2045(11)70188-7. Epub 2011 Aug 22.
4
Validation of a simplified HPV genotyping assay designed for cervical screening in low-resource settings.一种为资源匮乏地区宫颈筛查设计的简化人乳头瘤病毒基因分型检测方法的验证
J Clin Microbiol. 2025 Feb 19;63(2):e0163924. doi: 10.1128/jcm.01639-24. Epub 2024 Dec 31.
5
Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population-based cervical cancer screening studies from China.临床评价:以延长型 HPV 基因分型为宫颈癌筛查的 HPV 检测应用:来自中国九项基于人群宫颈癌筛查研究的个体患者数据的汇总分析。
Cancer Med. 2024 Jun;13(11):e7316. doi: 10.1002/cam4.7316.
6
AmpFire HPV and ScreenFire RS HPV validation trial.AmpFire HPV 和 ScreenFire RS HPV 验证试验。
Am J Clin Pathol. 2024 Jun 3;161(6):535-542. doi: 10.1093/ajcp/aqad181.
7
The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.特定型别人乳头瘤病毒感染对宫颈癌前病变和癌症检出的影响:美国机会性宫颈筛查的基于人群研究。
Int J Cancer. 2014 Aug 1;135(3):624-34. doi: 10.1002/ijc.28605. Epub 2014 Apr 15.
8
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.英格兰原发性人乳头瘤病毒子宫颈筛查的临床效果和成本效益:通过三轮筛查对 ARTISTIC 随机试验队列进行的扩展随访。
Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.
9
[Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].[不同HPV亚型感染合并细胞学异常状态下CIN2+/CIN3+风险的评估]
Zhonghua Zhong Liu Za Zhi. 2018 Mar 23;40(3):232-238. doi: 10.3760/cma.j.issn.0253-3766.2018.03.015.
10
[Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].[人乳头瘤病毒分型检测在子宫颈癌前病变和子宫颈癌筛查中的性能]
Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):252-256. doi: 10.3760/cma.j.cn112152-20190603-00346.

引用本文的文献

1
Use of Thermal Ablation in Low-Resource Settings: Experience From Three Multicenter Noninferiority Randomized Clinical Trials.低资源环境下热消融的应用:三项多中心非劣效性随机临床试验的经验
JCO Glob Oncol. 2025 Jun;11:e2500050. doi: 10.1200/GO-25-00050. Epub 2025 Jun 6.
2
Analytical performance of the ScreenFire HPV RS Zebra BioDome assay on four different qPCR platforms.ScreenFire HPV RS Zebra BioDome检测在四种不同qPCR平台上的分析性能。
Infect Agent Cancer. 2025 Apr 30;20(1):28. doi: 10.1186/s13027-025-00651-5.
3
Design and validation of ultra-compact metamaterial-based biosensor for non-invasive cervical cancer diagnosis in terahertz regime.

本文引用的文献

1
Use of risk-based cervical screening programs in resource-limited settings.资源有限环境下基于风险的宫颈癌筛查计划的应用。
Cancer Epidemiol. 2023 Jun;84:102369. doi: 10.1016/j.canep.2023.102369. Epub 2023 Apr 25.
2
Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis.全球 202 个国家和地区的宫颈癌筛查规划和年龄别覆盖估计:综述和综合分析。
Lancet Glob Health. 2022 Aug;10(8):e1115-e1127. doi: 10.1016/S2214-109X(22)00241-8.
3
Redesign of a rapid, low-cost HPV typing assay to support risk-based cervical screening and management.
用于太赫兹波段非侵入性宫颈癌诊断的基于超紧凑型超材料的生物传感器的设计与验证
PLoS One. 2025 Feb 3;20(2):e0311431. doi: 10.1371/journal.pone.0311431. eCollection 2025.
4
Exploring the application of dietary antioxidant index for disease risk assessment: a comprehensive review.探索膳食抗氧化指数在疾病风险评估中的应用:一项综述
Front Nutr. 2025 Jan 16;11:1497364. doi: 10.3389/fnut.2024.1497364. eCollection 2024.
5
Isothermal Nucleic Acid Amplification for Point-of-Care Primary Cervical Cancer Screening.用于即时护理原发性宫颈癌筛查的等温核酸扩增
Viruses. 2024 Nov 28;16(12):1852. doi: 10.3390/v16121852.
6
Validation of a simplified HPV genotyping assay designed for cervical screening in low-resource settings.一种为资源匮乏地区宫颈筛查设计的简化人乳头瘤病毒基因分型检测方法的验证
J Clin Microbiol. 2025 Feb 19;63(2):e0163924. doi: 10.1128/jcm.01639-24. Epub 2024 Dec 31.
7
Analytic performance of ScreenFire HPV RS assay Zebra BioDome format and its potential for large-scale population HPV screening.ScreenFire HPV RS检测斑马生物穹顶格式的分析性能及其在大规模人群HPV筛查中的潜力。
Infect Agent Cancer. 2024 Nov 29;19(1):59. doi: 10.1186/s13027-024-00622-2.
8
Study on the clinical characteristics, persistent infection capability and viral load of human papillomavirus type 26 single infection.人乳头瘤病毒 26 型单感染的临床特征、持续感染能力及病毒载量研究。
Virol J. 2024 Nov 23;21(1):301. doi: 10.1186/s12985-024-02582-w.
9
A cervical cancer control strategy for lower-resource settings: interventions to complement one-dose HPV vaccination.资源有限环境下的宫颈癌控制策略:补充一剂 HPV 疫苗接种的干预措施。
J Natl Cancer Inst Monogr. 2024 Nov 1;2024(67):417-423. doi: 10.1093/jncimonographs/lgae040.
10
The Future of Cervical Cancer Screening.宫颈癌筛查的未来。
Int J Womens Health. 2024 Oct 23;16:1715-1731. doi: 10.2147/IJWH.S474571. eCollection 2024.
一种快速、低成本的 HPV 分型检测方法的重新设计,以支持基于风险的宫颈癌筛查和管理。
Int J Cancer. 2022 Oct 1;151(7):1142-1149. doi: 10.1002/ijc.34151. Epub 2022 Jun 24.
4
Evaluation of an isothermal amplification HPV detection assay for primary cervical cancer screening.用于原发性宫颈癌筛查的等温扩增人乳头瘤病毒检测方法的评估
Infect Agent Cancer. 2020 Oct 23;15:65. doi: 10.1186/s13027-020-00328-1. eCollection 2020.
5
A rapid, high-volume cervical screening project using self-sampling and isothermal PCR HPV testing.一项使用自我采样和等温PCR HPV检测的快速、大批量宫颈筛查项目。
Infect Agent Cancer. 2020 Oct 22;15:64. doi: 10.1186/s13027-020-00329-0. eCollection 2020.
6
Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women.选择人乳头瘤病毒基因型以优化南非女性筛查试验的性能。
Cancer Med. 2020 Sep;9(18):6813-6824. doi: 10.1002/cam4.3329. Epub 2020 Jul 24.
7
Evaluation of Liquid Versus Dry Specimen Transport With a Newly Validated Isothermal Amplification High-Risk Human Papillomavirus Assay.采用新验证的等温扩增高危型人乳头瘤病毒检测方法评估液体与干燥样本运输
J Low Genit Tract Dis. 2020 Jul;24(3):243-246. doi: 10.1097/LGT.0000000000000546.
8
A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs.一项关于特定类型人乳头瘤病毒自然史及其对当代宫颈癌筛查项目影响的研究。
EClinicalMedicine. 2020 Apr 25;22:100293. doi: 10.1016/j.eclinm.2020.100293. eCollection 2020 May.
9
Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework.BD Onclarity HPV 检测在丹麦宫颈筛查项目中使用 SurePath 筛查样本的临床和分析性能,采用 VALGENT 框架。
J Clin Microbiol. 2020 Jan 28;58(2). doi: 10.1128/JCM.01518-19.
10
Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes.评价 TypeSeq,一种新型高通量、低成本、基于下一代测序的 51 种人类乳头瘤病毒基因型检测方法。
J Infect Dis. 2019 Oct 8;220(10):1609-1619. doi: 10.1093/infdis/jiz324.